Agilis is advancing innovative DNA therapeutics designed to provide long-term efficacy for patients with debilitating, often fatal, rare genetic diseases that affect the central nervous system.

CH Clara, BRI a. SC Borgia, DVM, BRI g. SC Arabica, BRI f 03. GIC Gatta, BRI g 03. CH Ino, BRI j. IC Negra, BRI f. CH Ori, BRI b. IC Perla, BRI g 03. IC Vesper, BRI g 03. SC Fado, DVM, BRI e. Django Nero, BRI n. Umrzeć - tego się nie robi kotu. Bo co ma począć kot.

You can rely on our decades of experience to simplify the complexities of server hardware components and requirements and deliver a finished package that hits the mark for your business. Versatile solutions for your needs. Exceptional performance without compromising reliability. Design and deployment of efficient infrastructure.

We specialize in human factors engineering, software consulting and performance-based training and labeling for medical devices and products. Through the application of human factors methods and software solutions that lead to better and more cost-effective user performance, Agilis helps its clients achieve faster regulatory clearance, higher user satisfaction and lower post-market support costs. Shorter and less costly product development cycle times.